Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years

Affiliations

Comment

Eoin P O'Sullivan et al. ACP J Club. 2008.

. 2008 Dec 16;149(6):4.

No abstract available

Comment on

10-year follow-up of intensive glucose control in type 2 diabetes.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. Holman RR, et al. N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. N Engl J Med. 2008. PMID: 18784090 Clinical Trial.

Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years.
Sherifali D. Sherifali D. Evid Based Nurs. 2009 Jan;12(1):14. doi: 10.1136/ebn.12.1.14. Evid Based Nurs. 2009. PMID: 19103832 No abstract available.
Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years.
O'Sullivan EP, Dinneen SF. O'Sullivan EP, et al. Evid Based Med. 2009 Feb;14(1):9-10. doi: 10.1136/ebm.14.1.9. Evid Based Med. 2009. PMID: 19181941 No abstract available.
A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
Morales A. Morales A. J Ark Med Soc. 2009 Oct;106(4):90-3. J Ark Med Soc. 2009. PMID: 19813399 Review.
Intensive therapy for diabetes through influence on innate immune system.
Li ZZ, Liu JB, Li L, Jiao L, Chen L. Li ZZ, et al. Med Hypotheses. 2009 Jun;72(6):675-6. doi: 10.1016/j.mehy.2009.01.028. Epub 2009 Mar 4. Med Hypotheses. 2009. PMID: 19264419
Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
Roman G, Hancu N. Roman G, et al. Horm Metab Res. 2009 Feb;41(2):116-22. doi: 10.1055/s-0028-1128144. Epub 2009 Feb 12. Horm Metab Res. 2009. PMID: 19214921 Review.